Skip to main content
Premium Trial:

Request an Annual Quote

Interleukin to Build CLIA-Approved DNA Testing Lab

NEW YORK, April 13 (GenomeWeb News) - Interleukin Genetics has signed a new lease that expands its Waltham, Mass.-based facilities from 6,000 to 19,000 square feet, the company said today.

Interleukin said it would use the new space to build a CLIA (Clinical Laboratory Improvement Act)-certified DNA laboratory to process DNA tests that it plans to launch next year.

In line with its expansion plans, Interleukin hired four new managers: Taha Keilani as medical director; Christopher Palatucci as senior director of business development and licensing; Paul Voegelin as director of operations and planning; and Gary Breton as DNA laboratory manager.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.